US FDA's device reviewers need more training on handling of scientific disagreements, says OIG
This article was originally published in Clinica
Device reviewers and their managers at the US Food and Drug Administration need to be better trained on resolving scientific disagreements amongst themselves, the Office of Inspector General at the Department of Health and Human Services has recommended in a new report.
You may also be interested in...
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.